Franek Technologies says that the USA is better prepared to deal with the public health threat of biological terrorism due to its efforts
By teaming with the US Army and public health departments nationwide, working on AdvaMed's medical technology preparedness working group, and developing educational tools for laboratories, Franek's expertise is a required critical safeguard in the USA's laboratories against power fluctuations and failure that can paralyze their ability to reliably detect biohazard agents in air, food, soil, and mail.
Following the terrorist attacks on 11 September 2001, Franek teamed with forensics agencies and public health departments to protect research and analysis of threatening biological agents.
Franek has worked with the FBI and the Royal Canadian Mounted Police, as well as being selected as the power protection source for the US Army's automated biological agent testing system (Abats).
Additionally, Franek developed a certified LPS solution for the State of New York Medical Examiners Department to provide rapid response support of DNA detection for victim identification.
As active members of AdvaMed's (Advanced Medical Technology Association) Medical Technology Preparedness Working Group, Franek works with industry leaders to identify how our nation can improve rapid response should another incident occur.
The Working Group was established in the wake of 9-11 to ensure that America's public health system and military are prepared to make use of the latest medical technologies, including rapid anthrax diagnostic tests and novel vaccine delivery, in times of national crisis.
To emphasise the importance of laboratory contingency management, Franek has developed many educational resources, such as journal articles, white papers, and online tools, to illustrate to laboratories how to remain viable and active, 24/7.
Franek's uninterruptible power solutions condition laboratory power to provide supplemental (backup) power reserves.
With such protection, when power fluctuations or failure occur, mission critical instrumentation is protected and reportable results remain true and compliant.
"We, at Franek Technologies, have always taken a leadership position in assisting the laboratory and scientific marketplace," explained John Franek, president and CEO, Franek Technologies.
"This assistance is especially important after the incidents of 9-11 to safeguard these critical institutions and the research that they provide in developing new vaccines and diagnostic tests that will be utilised today and in the future for mitigating bioterrorist threats."
